Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 613 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
10 Apr 2019
CVP,Strategy/Corp Development
Sold, plan not stated
300
$56.99K
1.5%
9 Apr 2019
CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
4,186
$787.93K
9.4%
5 Apr 2019
CVP, Japan & Intercontinental
Sold, plan not stated
4,650
$880.29K
12.9%
1 Apr 2019
CVP, TAVR
Sold, plan not stated
6,716
$1.29M
5.5%
25 Mar 2019
CVP, Japan & Intercontinental
Sold, plan not stated
4,650
$876.99K
13.0%
25 Mar 2019
CVP, EMEA, Canada, Latin Amer
Sold, plan not stated
4,186
$789.48K
9.4%
15 Mar 2019
CVP, Critical Care
Sold, plan not stated
1,146
$205.25K
5.1%
15 Mar 2019
CVP, Critical Care indirect
Sold, plan not stated
328
$58.74K
14.2%
13 Mar 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$966.52K
22.5%
8 Mar 2019
Chairman & CEO
Sold, plan not stated
32,800
$5.51M
43.2%
1 Mar 2019
CVP, TAVR
Sold, plan not stated
6,716
$1.15M
5.5%
22 Feb 2019
VP, Corporate Controller
Sold, plan not stated
500
$87.52K
3.6%
21 Feb 2019
VP, Corporate Controller
Sold, plan not stated
2,623
$459.22K
16.5%
21 Feb 2019
CVP, Critical Care
Sold, plan not stated
1,146
$202.09K
4.8%
21 Feb 2019
CVP, Critical Care indirect
Sold, plan not stated
328
$57.84K
12.5%
13 Feb 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$977.63K
22.5%
12 Feb 2019
Chairman & CEO
Sold, plan not stated
32,800
$5.80M
43.2%
5 Feb 2019
CVP, Japan & Intercontinental
Sold, plan not stated
4,000
$686.72K
11.4%
4 Feb 2019
CVP, THV Replacement
Sold, plan not stated
6,716
$1.14M
5.5%
16 Jan 2019
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$891.17K
22.5%
15 Jan 2019
CVP, Critical Care & Vascular
Sold, plan not stated
372
$57.66K
1.4%
15 Jan 2019
CVP, Critical Care & Vascular indirect
Sold, plan not stated
328
$50.84K
11.1%
7 Jan 2019
CVP, THV Replacement
Sold, plan not stated
6,716
$994.98K
5.5%
4 Jan 2019
CVP, Japan & Intercontinental
Sold, plan not stated
4,000
$581.32K
11.4%
3 Jan 2019
Chairman & CEO
Sold, plan not stated
32,800
$4.72M
43.2%
21 Dec 2018
Chairman & CEO
Sold, plan not stated
32,800
$4.79M
43.2%
14 Dec 2018
CVP, THV Replacement
Sold, plan not stated
6,300
$1.02M
5.2%
14 Dec 2018
CVP, Critical Care & Vascular
Sold, plan not stated
372
$60.51K
1.4%
14 Dec 2018
CVP, Critical Care & Vascular indirect
Sold, plan not stated
328
$53.35K
10.0%
12 Dec 2018
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$907.45K
22.5%
6 Dec 2018
CVP, Japan & Intercontinental
Sold, plan not stated
3,800
$592.31K
10.8%
29 Nov 2018
Director indirect
Sold, plan not stated
1,319
$212.30K
4.4%
21 Nov 2018
VP, Corporate Controller
Sold, plan not stated
2,600
$398.27K
16.4%
20 Nov 2018
VP, Corporate Controller
Sold, plan not stated
5,259
$805.38K
28.4%
19 Nov 2018
Chairman & CEO
Sold, plan not stated
32,900
$4.96M
43.3%
19 Nov 2018
Director indirect
Sold, plan not stated
13,578
$2.04M
69.2%
15 Nov 2018
CVP, THV Replacement
Sold, plan not stated
6,300
$932.15K
5.2%
15 Nov 2018
CVP, Critical Care & Vascular
Sold, plan not stated
372
$55.04K
1.3%
15 Nov 2018
CVP, Critical Care & Vascular indirect
Sold, plan not stated
328
$48.53K
9.1%
14 Nov 2018
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$822.91K
21.6%
6 Nov 2018
CVP, Japan & Intercontinental
Sold, plan not stated
15,000
$2.25M
23.9%
5 Nov 2018
CVP, Japan & Intercontinental
Sold, plan not stated
18,800
$2.84M
23.0%
29 Oct 2018
Chairman & CEO
Sold, plan not stated
32,900
$4.63M
43.3%
15 Oct 2018
CVP, THV Replacement
Sold, plan not stated
6,300
$898.63K
5.2%
15 Oct 2018
CVP, Critical Care & Vascular
Sold, plan not stated
372
$53.06K
1.3%
15 Oct 2018
CVP, Critical Care & Vascular indirect
Sold, plan not stated
328
$46.79K
8.3%
10 Oct 2018
CVP,Strategy/Corp Development
Sold, plan not stated
5,500
$811.25K
21.6%
5 Oct 2018
CVP, Japan & Intercontinental
Sold, plan not stated
3,800
$580.60K
4.7%
14 Sep 2018
CVP, THV Replacement
Sold, plan not stated
6,300
$925.79K
5.2%
12 Sep 2018
Chairman & CEO
Sold, plan not stated
32,900
$4.74M
43.3%
Showing 451–500 of 613. ← Newer Page 10 of 13 Older →